Plasminogen-receptorKT: plasminogen activation and beyond
نویسندگان
چکیده
منابع مشابه
1 THE NOVEL PLASMINOGEN RECEPTOR , PLASMINOGEN RECEPTORKT ( Plg - RKT ) , REGULATES CATECHOLAMINE RELEASE
THE NOVEL PLASMINOGEN RECEPTOR, PLASMINOGEN RECEPTORKT (Plg-RKT), REGULATES CATECHOLAMINE RELEASE Hongdong Bai, Nagyung Baik, William B. Kiosses, Stan Krajewski, Lindsey A. Miles and Robert J. Parmer From Department of Medicine, University of California San Diego, La Jolla, CA 92037, USA and Veterans Administration San Diego Healthcare System, San Diego, CA 92161, USA, The Scripps Research Inst...
متن کاملPlasminogen activation and cancer.
Breakdown of the extracellular matrix is crucial for cancer invasion and metastasis. It is accomplished by the concerted action of several proteases, including the serine protease plasmin and a number of matrix metalloproteases. The activity of each of these proteases is regulated by an array of activators, inhibitors and cellular receptors. Thus, the generation of plasmin involves the pro-enzy...
متن کاملInteraction of plasminogen and fibrin in plasminogen activation.
Glu1-, Lys77-, miniplasminogens, kringle 1-3, kringle 1-5A, and kringle 1-5R were able to bind with fibrin, while microplasminogen and kringle 4 did not bind significantly. Kringle 1-5A, but not kringle 1-3, effectively inhibited the binding of Glu1-, Lys77-, and miniplasminogens with fibrin. Miniplasminogen also inhibited the binding of Glu1-plasminogen with fibrin. The binding of kringle 1-3 ...
متن کاملRegulation of Plasminogen Activation
The main components of plasminogen activation include plasminogen, tissue plasminogen activator (tPA), urokinase plasminogen activator (uPA), urokinase plasminogen activator receptor (uPAR), and plasminogen activator inhibitors-1 and -2 (PAI-1, PAI-2 ). uPA and its receptor uPAR are known to be important in cell migration/adhesion. In these studies, we show that uPAR was anchored in focal conta...
متن کاملPlasminogen Activation With Streptokinase
Background. Platelet activation occurs in vivo during pharmacologic thrombolysis and may contribute to recurrent thrombosis. Plasmin does not directly activate platelets except at high concentrations; thus, the mechanisms for platelet activation during thrombolysis remain undefined. Increases in thrombin activity also occur in patients treated with fibrinolytic agents and may contribute to acti...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Thrombosis and Haemostasis
سال: 2016
ISSN: 1538-7933
DOI: 10.1111/jth.13541